Objective: This study examines whether overweight in midlife increases dementia risk later in life. Methods: In 1963 body mass index was assessed in 1152 participants of The Swedish Twin Registry, at the age of 45-65 years. These participants were later screened for dementia in a prospective study with up to 40 years follow-up. A total of 312 participants were diagnosed with dementia. Results: Logistic regression analyses adjusted for demographic factors, smoking and alcohol habits, indicated that men and women categorized as overweight in their midlife had an elevated risk of dementia (OR ¼ 1.59; 95% CI: 1.21-2.07, P ¼ 0.002), Alzheimer's disease (OR ¼ 1.71; 95% CI: 1.24-2.35, P ¼ 0.003), and vascular dementia (OR ¼ 1.55; 95% CI: 0.98-2.47, P ¼ 0.059). Further adjustments for diabetes and vascular diseases did not substantially affect the associations, except for vascular dementia (OR ¼ 1.36; 95% CI: 0.82-2.56, P ¼ 0.116), reflecting the significance of diabetes and vascular diseases in the etiology of vascular dementia. There was no significant interaction between overweight and APOE e4 status, indicating that having both risk factors does not have a multiplicative effect with regard to dementia risk. Conclusions: This study gives further support to the notion that overweight in midlife increases later risk of dementia. The risk is increased for both Alzheimer's disease and vascular dementia, and follows the same pattern for men and women.
Introduction
The long-term effects of overweight on physical health and survival are well known. Recent research is now even including potential negative effects on cognition in later life. [1] [2] [3] [4] [5] [6] In two recent systematic review articles 7, 8 on overweight and risk of dementia it was proposed that high body mass index (BMI) is independently associated with the risk of dementia. According to the reviews, the studies that reported significant associations had younger samples at baseline and longer follow-up periods. Overweight should be measured in midlife to reveal the association with subsequent dementia because people often lose weight before diagnosis 9 and early in the dementia phase. 10 This fact is bound to blur the association between overweight and dementia in older samples. Another reason is that BMI is a better measure of adiposity in younger samples as lean body mass is replaced by fat with increasing age. 11 Thus, it is possible for old people to have relatively low BMI although they can have relatively high body fat. Finally, and most importantly, measuring overweight in midlife may reflect a more valid perspective on a person's lifelong exposure to overweight, especially given the fact that most people tend to gain rather than lose weight in adulthood. Thus, when in the life course a risk factor for dementia is measured, it determines whether and how the association is characterized. 12, 13 Studies that have addressed potential sex differences in the association between overweight and dementia risk indicate that overweight may be a stronger risk factor for women compared with men. 3, 14 Hayden et al. 14 who used BMI in a sample of people aged 65 years and older to predict incident dementia, found an increased risk only for women; however, the authors reported a problem with low statistical power in the analyses of men. By using midlife assessment of BMI and skinfold thickness, 3 it was found that midlife BMI predicted dementia among women only, whereas midlife skinfold thickness predicted dementia in both sexes, suggesting that BMI is an inaccurate measure of adiposity in men.
A related question is if overweight is differentially associated with the most frequent types of dementia, that is, Alzheimer's disease (AD) and vascular dementia (VaD). This has only been examined in three studies. 1, 14, 15 Two studies reported that overweight increases the risk of AD and not VaD in women. 1, 14 In the study of Whitmer et al.
15
overweight (BMI between 25 and 30) increased the risk of AD and VaD to the same extent (approximately a two-fold increased risk), whereas obesity (BMIX30) was more strongly related to VaD, indicating a five-fold risk, as compared with a three-fold risk of AD. In a recent study by the same group, midlife central obesity was found to predict dementia. 4 In the investigation of the association between overweight and dementia it is important to include all covariates that are correlated with overweight and dementia and might affect the association, such as age, sex, lifestyle factors (education, smoking and alcohol consumption), diabetes, vascular diseases and APOE e4 carrier status. The majority of the studies addressing this issue include all relevant covariates, with the exception of APOE e4 status.
The purpose of our study is to examine if overweight in midlife is related to increased risk of dementia in later life. We also examine if the risk is similar for men and women, and if overweight is differentially related to AD and VaD. Furthermore, the potential effect of APOE e4 allele will be examined.
Methods

Participants
Data on BMI come from the initial surveys that were administered to form the Swedish Twin Registry. The Swedish Twin Registry was established in the late 1950s to study smoking and alcohol consumption in relation to potential risk of cancer and cardiovascular diseases. 16 ). Overweight is normally defined as a BMI between 25 and 30, whereas obesity is defined as a BMI greater than 30. In our sample, however, less than 5% were obese according to this criterion. To gain statistical power, we therefore applied a slightly different categorization with BMI dichotomized into two categories with the top 25% of the distribution defined as overweight (BMIX26.5; coded as 1) and all others defined as normal weight (coded as 0).
The information on heights and weights were selfreported, which is potentially a subject to bias. However, analyses completed in the SATSA comparing self-reported and measured information on heights and weights (within a 1 year period) resulted in a correlation of 0.97 for height and 0.95 for weight. 20 The mean differences (±s.d.) between selfreported and measured values were 1.2 ± 2.4 cm for height and 0.8 ± 4.0 kg for weight.
Dementia and vascular risk factors
The OCTO-Twin and the SATSA are longitudinal studies with repeated assessments at a 2-to 3-year time schedules. Thus, the participants have been evaluated continuously across the study period with respect to dementia and vascular risk factors. Clinical diagnoses of dementia followed the DSM-III-R criteria. 21 All individuals were assessed with a cognitive test battery during an in person visit. Individuals suspected for dementia were given a diagnostic workup, including an interview with an informant about memory and cognitive problems, review of in person cognitive test protocols and medical records. 22 Findings were presented at a multidisciplinary consensus diagnosis conference, attended by the clinicians and chaired by a psychologist who had not met the participant. Subtypes of dementia were assigned following NINCDS/ADRDA criteria for Alzheimer's disease 23 and the NINDS-AIREN criteria for vascular dementia. 24 All clinical diagnoses were completed without reference to neuroimaging. Prevalence rates of dementia in SATSA and OCTO-Twin have been found to resemble other similar studies such as the Kungsholmen study 25 in Sweden, and the Framingham study 26 in the United States.
A total of 312 individuals received a dementia diagnosis: 181 were diagnosed with AD; 69 with VaD; and 62 with Overweight in midlife and risk of dementia LB Hassing et al mixed, secondary or unspecified dementia. Mean age at recorded dementia diagnosis was 83 years (range 62-96 years), and did not differ between the normal weight and the overweight groups. The vascular risk factors of interest for this study are smoking and alcohol habits, arterial hypertension, congestive heart failure, myocardial infarction, diabetes and stroke. The information on smoking and alcohol habits comes from the surveys in the sixties as well as from the longitudinal aging studies (SATSA and OCTO-Twin). The smoking variable was coded as 0 for non-smokers and 1 for current or previous smokers. The alcohol variable was coded as 0 for alcohol consumers and 1 for those who never use alcohol. Information on diabetes and vascular diseases was obtained through self-reports and through a review of medical records. If there was any notification of a disease or a history of self-report the person was coded as having the disease. The following diseases were included in the analyses: hypertension, congestive heart failure, myocardial infarction, diabetes and stroke (0 ¼ without the disease, 1 ¼ with the disease).
APOE e4 carrier status was coded as 0 for non-carriers of the e4 allele and as 1 for those carrying 1 or 2 copies of the e4 allele. Information regarding APOE e4-carrier status was available for only 732 individuals. Therefore, APOE e4 status will not be included in the main analyses. However, it will be included in one complementary analysis in which potential interaction with overweight on dementia risk will be examined.
Data analyses
Group differences between the normal weight group and overweight group in background characteristics were analyzed with t-tests and w 2 -tests. Odds Ratio for dementia was calculated using an extension of the generalized linear model known as generalized linear mixed model (also known as hierarchical generalized linear model 27 ) to account for the hierarchical structure in the data when accounting for the dependency associated with twin pair status. Within this modeling procedure we analyzed the logit function of the probability of an event of diagnosis of dementia as a conditional function of BMI, eight dummy-coded covariates (that is, gender, smoking, alcohol habit, hypertension, congestive heart failure, myocardial infarction, diabetes and stroke), two continuous covariates (age and education) and a random effect of the intercept reflecting estimated variability across the twin pairs. The random effect was assumed to take a normal distribution with a mean of zero. Risk of dementia was first analyzed for the total sample and then separately for men and women. In the next step, we examined if BMI was differentially related to AD and VaD: this was first analyzed for the total sample, then separately for men and women. Two models were run in each case. Model I included age, gender, smoking and alcohol habit as covariates. In Model II, diabetes and vascular diseases (hypertension, congestive heart failure, myocardial infarction and stroke) were added along with the covariates included in Model I. The analyses were conducted using the GLIMMIX procedure in SAS version 9.1. 28 The statistical analyses regarding the association between overweight and dementia were based on one-tailed tests using the conventional a level of 0.05.
Results
Sample characteristics
The sample characteristics are shown in Table 1 . There were statistically significant differences between the normal weight group and the overweight group, such that the overweight group had fewer years of education, comprised more individuals who did not use alcohol, had more individuals with hypertension, congestive heart failure and diabetes (Po0.05).
Participant characteristics comparing controls with dementia cases are presented in Table 2 . There were statistically significant differences between controls and cases, such that the dementia group had more women, were older, had fewer years of education, had shorter survival, comprised more individuals who did not use alcohol, had more prevalent congestive heart failure, stroke and APOE e4 carriers, and a higher BMI (Po0.05).
Risk of dementia in relation to midlife BMI
The results from the logistic regression analyses that were all corrected for twinship are presented in Table 3 . Model I (adjusted for demographics, smoking and alcohol use) showed that midlife overweight was associated with greater risk of dementia, such that those with a BMI above the third quartile had a 59% greater risk of getting dementia in old age as compared with those with lower BMI. Further adjustments for diabetes and vascular diseases in Model II did not substantially change this association. Among these covariates, only stroke came out as a significant covariate (OR ¼ 1.59).
When BMI was examined in relation to AD the same pattern was found as with all dementia, although the association was stronger in terms of risk, OR ¼ 1.71 in Model I and OR ¼ 1.68 in the fully adjusted model. None of the vascular risk factors were statistically significant. Concerning VaD, the risk associated with higher BMI fell short out of significance in Model I, (OR ¼ 1.55; P ¼ 0.059). However, the risk was substantially reduced in Model II by including diabetes and vascular diseases (OR ¼ 1.36; P ¼ 0.162), reflecting the significance of these factors in the etiology of VaD. In this model, congestive heart failure (OR ¼ 1.98) and stroke (OR ¼ 6.97) were significantly related to risk of VaD (Po0.05), whereas diabetes was marginally significant (OR ¼ 1.65; P ¼ 0.067). The sex-stratified analyses on BMI and dementia risk showed the same pattern among men and Overweight in midlife and risk of dementia LB Hassing et al women, therefore, these results will not be presented separately.
A complementary analysis was conducted in which APOE e4 carrier status was included in the analysis as a covariate as well as the interaction term between BMI and APOE e4 status. As only 732 individuals had information regarding APOE e4 status, we first analyzed BMI status in relation to all dementia in the subsample of 732 individuals not including APOE e4 status. This analysis resulted in an OR of 1.62 (95% CI ¼ 1.17-2.24, P ¼ 0.008) for BMI status (as compared with OR of 1.59 for N ¼ 1152). When APOE e4 status was included as a covariate, the association between BMI status and dementia was somewhat weaker, although still statistically significant (OR ¼ 1.57, 95% CI ¼ 1.13-2.20, P ¼ 0.013). For APOE e4 status the OR was 3.99 (95% CI ¼ 2.96-5.38, Po0.001), confirming the well-established role of APOE e4 as a risk factor for dementia. The interaction between BMI and APOE e4 was not statistically significant (P ¼ 0.781), indicating that having both risk factors does not have a multiplicative effect on dementia risk but rather an additive effect (see Table 4 ).
Discussion
This study examined if overweight in midlife is related to risk of dementia in old age. Our results showed that midlife overweight significantly increased the risk of dementia in old age, even after controlling for known comorbid factors related to vascular risk. Further, the risk was increased for both AD and VaD. However, by controlling for diabetes and vascular diseases the association between BMI and VaD was Overweight in midlife and risk of dementia LB Hassing et al reduced to a non-significant level. This was not the case for AD. Finally, the sex-stratified analyses indicated the same pattern for men and women.
There are few studies that have examined the long-term risk of overweight in relation to dementia. This is reasonable given the practical demands associated with studies requiring extensive follow-up time. Consequently, studies to date have often used medical records to gain data on dementia diagnoses, a procedure that is unlikely to capture all cases and include information on dementia subtypes. In our study, the dementia diagnoses were made through a thorough clinical procedure resulting in a highly confident outcome diagnosis. On the other hand, the BMI measure is based on self reports on weight and height, leaving a potential risk for inaccuracy in the report. However, correlational analyses conducted on SATSA, 20 comparing self-reported and measured data on heights and weights, resulted in correlation of 0.97 for height and 0.95 for weight, supporting a notion of valid and reliable self-reported data. There are other measures of overweight that probably better reflect adiposity than BMI, such as hip-to-waist ratio and circumference that we unfortunately did not have in our data. Another issue that needs to be highlighted when interpreting the results from this study is the issue of potential survival bias. Included in our study are people aged 45-65 years at baseline and who were alive at the start of the aging studies (SATSA and OCTO-Twin) on dementia. This implies that the participants were at the age of 69 þ years (for the SATSA) and 80 þ years (for the OCTO-Twin) at inclusion, meaning that the results can only be generalized to people who survive into that age. Another issue, related to the sample, is that it is constituted of twins, which means that there is a dependency within twin pairs. This was, however, dealt within the statistical analyses by using multilevel models that account for the dependency within pairs. Generally, our results are in congruence with results from studies where overweight is measured in midlife and the follow-up time for the dementia outcome is extensive.
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When we analyzed the risk of dementia separately for the sexes the same pattern was found for men and women, a result that contradicts one study that reported greater risk for women. 14 Whitmer et al. 3 found that the way adiposity is measured results in different dementia risk for the sexes, such that BMI predicted dementia only among women whereas skinfold thickness was a significant predictor for both sexes. Thus, there seems to be no substantial differences between men and women in this matter. Potential mechanisms by which overweight increases the risk of compromised brain functioning in later life include vascular disease, diabetes, genetics and inflammatory processes. Overweight increases the risk of hypertension, diabetes mellitus and stroke, all three known risk factors for dementia. Our study, along with other studies show that even after controlling for these comorbid risk factors, overweight is still a significant risk factor of dementia. This does not, however, rule out the possibility that these diseases are of importance, especially given the fact that both hypertension and diabetes-related conditions are underdiagnosed and underreported in the general population. APOE e4 carrier status is a known risk factor for vascular disease and dementia. 29, 30 In our study, there were somewhat more APOE e4 carriers in the overweight group. In the analysis in which APOE e4 status was included as a covariate, overweight remained a significant independent predictor for dementia. Most interestingly, however, was that overweight did not interact with APOE e4 status on dementia risk in a multiplicative manner, supporting earlier findings from the Finnish CAIDE study. 31 Another factor of importance is inflammation that has been shown to be associated with vascular disease, 32 obesity, 33,34 cognitive decline 35 and dementia. 36 However, the direction of the associations between inflammation and the above conditions is controversial. In a recent study 35 it was demonstrated that the effects of the metabolic syndrome on cognitive decline were mediated by inflammation, such that those with high inflammation and the metabolic syndrome had a greater risk of cognitive decline compared with those with low inflammation but a metabolic syndrome. To summarize, in congruence with the few studies that have assessed overweight in midlife and risk of dementia in later life, our study gives further support to the conclusion that overweight is a significant risk factor for dementia.
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